Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the ...

Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...

We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...

The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.

A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...

(AP Photo/Jose Luis Magana) WASHINGTON (AP) — The Environmental Protection Agency has issued new guidance directing that spending items greater than $50,000 now require approval from Elon Musk’s ...

“So that we don’t learn five years after Vioxx was approved that 38,000 Americans died from it,” he said. Open questions: But the Johns Hopkins surgeon also said the FDA could potentially ...

including telehealth and drug companies that sell compounded versions of FDA-approved drugs. The Associated Press Health and Science Department receives support from the Howard Hughes Medical ...

ENCELTO is the first and only FDA-approved treatment available for MacTel. The approval was based on results from two phase 3 trials which demonstrated that after placement, of the implant ...

The FDA is expected to decide on treatments for ... The Company is seeking approval for acute treatment of migraine with or without aura.